The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
Nation and World
A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans.
The announcement sets the stage for the biggest vaccination campaign in British history and came just ahead of what experts are warning will be a long, dark winter.
Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that it protects older people most at risk of dying from COVID.
Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus.
A 25-year-old Washoe County man is the nation’s first COVID-19 patient proven to have been reinfected by the new coronavirus, according to the Nevada State Public Health Laboratory in Reno.
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a new poll from The Associated Press-NORC Center for Public Affairs Research.
U.S. health regulators on Tuesday OK’d the first coronavirus test that allows people to collect their own sample at home.
President Donald Trump signed the $8.3 billion coronavirus emergency spending bill Friday morning, before traveling to Tennessee to survey tornado damage.
In the past two months, “coronavirus” has become a household word. But how much do we know about the virus and the disease it causes, COVID-19?
The U.S. is banning travel to Iran in response to the outbreak of the new coronavirus and elevating travel warnings to regions of Italy and South Korea.
